Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Usp22i-S02 is an inhibitor of ubiquitin-specific protease 22 (USP22).1 It increases the levels of ubiquitinated forkhead box protein P3 (Foxp3), a target of Usp22, in primary mouse regulatory T cells (Tregs) when used at concentrations of 10, 15, or 20 µM. In vivo, Usp22i-S02 (20 mg/kg per day for five days) reduces tumor volume and increases intratumoral levels of CD4+CD8+ T cells in an LLC1 murine lung cancer model.
WARNING This product is not for human or veterinary use.
1. A deubiquitination module essential for Treg fitness in the tumor microenvironment. Sci. Adv. 8(47), eabo4116 (2022).